Company intelligence / Profile preview

Genepharm S.A.

Ownership: Private
Employees: ~499
Development stage: Commercial

Overview

Genepharm S.A. is a leading Greek pharmaceutical company specializing in the development, manufacturing, marketing, and distribution of generic pharmaceutical products. The company operates two advanced production facilities compliant with EU GMP standards and has a global presence in over 90 countries through strategic alliances. Its portfolio covers both conventional and oncological solid dosage forms with significant annual production capacity

Therapeutic areas: Men's HealthOncologyPulmonologyEndocrinologyHematologyOtherGastroenterologyCardiovascularNeurology
Modalities: Small molecules (tablets, capsules)Oncology drugs (oncological solids)
Industry: Biotech

Partnerships

Collaborates with some of the most well-known pharmaceutical companies worldwide through licensing and supply agreements

Beyond the preview

Go deeper on Genepharm S.A..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genepharm S.A..

Explore the full profile